Stephen Betz
Founder en CRINETICS PHARMACEUTICALS, INC. .
Fortuna: 4 M $ al 29/02/2024
Perfil
Stephen F.
Betz founded Crinetics Pharmaceuticals, Inc. Mr. Betz is Chief Scientific Officer at this company.
Mr. Betz previously was Director-Endocrinology & Metabolism at Neurocrine Biosciences, Inc. and Head-Laboratory Efforts at GeneFormatics, Inc.
Mr. Betz received an undergraduate degree from the University of Delaware and a doctorate from The University of North Carolina at Chapel Hill.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
18/03/2024 | 92 643 ( 0.14% ) | 4 M $ | 29/02/2024 |
Cargos activos de Stephen Betz
Empresas | Cargo | Inicio |
---|---|---|
CRINETICS PHARMACEUTICALS, INC. | Founder | 01/01/2008 |
Antiguos cargos conocidos de Stephen Betz.
Empresas | Cargo | Fin |
---|---|---|
NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/05/2009 |
GeneFormatics, Inc. | Corporate Officer/Principal | 01/01/2003 |
Formación de Stephen Betz.
University of Delaware | Undergraduate Degree |
The University of North Carolina at Chapel Hill | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
NEUROCRINE BIOSCIENCES, INC. | Health Technology |
CRINETICS PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
GeneFormatics, Inc. | Health Technology |